Mason Bioengineering Alliance

The Mason Bioengineering Alliance is a distinguished group of accomplished individuals from our biomedical and health sciences community.

The alliance supports the mission and activities of George Mason University’s Department of Bioengineering. The alliance is the critical industry and institutional advisor to the department’s activities and programs, helping to lead the definition and execution of the department’s strategic research plan including the components of education, research, commercialization, and fundraising. This Advisory Board is composed of 30 members:


  • Charles Anamelechi, Becton-Dickinson
  • Jeff Arndt, Senior System Engineer – KBR
  • Krishna Balakrishnan, Senior Technology Transfer Manager – National Center for Advancing Translational Sciences (NCATS), NIH
  • Peter Basser, Senior Investigator – Intramural Research Program (IRP); NIH Head – Section on Quantitative Imaging and Tissue Sciences (SQITS), Associate Scientific Director (ASD), Division of Imaging, Behavior and Genomic Integrity (DIBGI), and Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH)
  • Robert Caldwell, President & CEO – Strategic Health Solutions LLC
  • Vizma Carver, Founder, and CEO – Carver Global Health Group LLC
  • Jeff Conroy, CEO – Embody, Inc.
  • Kevin Cleary, Scientific Lead, The Sheikh Zayed Institute for Pediatric Surgical Innovation – Children's National Medical Center
  • John Deeken, MD, President – Inova Schar Cancer Institute, Inova Fairfax Hospital; Senior Vice President – Inova Health System; Professor of Medicine – University of Virginia
  • Ross Dunlap – CEO, Ceres Nanosciences  
  • Arthur Edge, Associate Director Global Technical Operations – AstraZeneca
  • Stanley Thomas Fricke, Director of Medical Physics – Department of Radiology, Georgetown University
  • Thomas Axel Haag,  Managing Partner – Linden Lake Venture Capital
  • David J. Hamilton,  Neuroscientist - Intelligent Mission Consulting Services (IMCS)
  • Richard Hughen, CEO – Linshom Management LLC
  • Erin Johnson, Executive Director of Operations – Vaccines Expansion, Merck
  • Chris Juncosa, Life Sciences Consultant – Dalya Partners
  • Neal Koller, Chairman, and CEO – Alphyn Biologics LLC
  • R. Prakash Kolli, CEO and Founder – Blue Point Materials Research LLC
  • John Newby, CEO – Virginia Bio
  • Nnamdi Nwachukwu, Vice President, Regulatory Science & Quality – RRD International
  • Roland Probst,  Founder, and Chief Innovation Officer – ACUITYnano LLC
  • Steven Roberts, Senior Manager, Scientific Collaborations – GSK Vaccines
  • Mahesh B. Shenai, Clinical Director of Inova Neurosurgery, Director of Functional and Restorative Neurosurgery – Inova Fairfax Medical Campus
  • Morgan K. Sisk, Simulation Software Engineer – Northrop Grumman
  • Michael Tarlov, Chief – Biomolecular Measurement Division, National Institute of Standards and Technology
  • Marinka Tellier, PhD, Director of Regulatory Affairs – Blue Lake Technology
  • Eric W. Vollmecke, Deputy Director, Rapid Prototyping Research Centre - George Mason University
  • Irving Weinberg, MD, President – Weinberg Medical Physics, Inc.
  • Sridevi Polavaram, Senior AI Engineer, MITRE Labs